Autopsy report · NCT00159757

12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“See Detailed Description for Termination Reason”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 10 months after it had already started.
Ran for about 1 year 3 months before it stopped.
150 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 4
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Sponsor type: Industry
Conditions: Schizophrenia
Interventions: ziprazidone
Participants: 150
Sites: 8
Countries: Hungary

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.